定量磁敏感成像在中枢神经系统中的研究进展及临床应用
Research Progress and Clinical Application of Quantitative Magnetic Sensitivity Imaging in the Central Nervous System
DOI: 10.12677/ACM.2023.13112387, PDF,   
作者: 方胜哲, 丁 爽:新疆医科大学第一附属医院影像中心,新疆 乌鲁木齐
关键词: 定量磁敏感成像中枢神经系统铁沉积Quantitative Susceptibility Mapping Central Nervous System Iron Deposition
摘要: 定量磁敏感成像(QSM)是一种基于组织磁化率特性的新的非侵入性磁共振技术,可以量化局部组织的磁化率差异。QSM在监测血氧饱和度、区分微出血及钙化、显示含铁血黄素沉积等方面具有很大的优势。目前QSM在铁代谢相关性疾病、神经退行性疾病、脑血管性疾病中已展开了大量应用及研究,其在大脑以外的应用因易受呼吸和心跳引起的运动伪影的干扰而具有挑战性,本文就QSM在中枢神经系统的最新的研究进展与临床应用进行综述。
Abstract: Quantitative susceptibility mapping (QSM) is a new non-invasive magnetic resonance imaging tech-nique based on tissue magnetization characteristics. It allows for the quantification of local tissue susceptibility differences. QSM has significant advantages in monitoring blood oxygen saturation, distinguishing microbleeds and calcifications and displaying iron deposition. Currently, there has been a considerable amount of application and research on QSM in iron metabolism-related diseas-es, neurodegenerative diseases, and cerebrovascular diseases. However, its application outside of the brain is challenging due to motion artifacts caused by respiration and heartbeat interference. This article provides a comprehensive review of the latest applications and research progress of QSM in the central nervous system.
文章引用:方胜哲, 丁爽. 定量磁敏感成像在中枢神经系统中的研究进展及临床应用[J]. 临床医学进展, 2023, 13(11): 17043-17049. https://doi.org/10.12677/ACM.2023.13112387

参考文献

[1] Nikparast, F., Ganji, Z., Danesh Doust, M., Faraji, R. and Zare, H. (2022) Brain Pathological Changes during Neuro-degenerative Diseases and Their Identification Methods: How Does QSM Perform in Detecting This Process? Insights Imaging, 13, Article No. 74. [Google Scholar] [CrossRef] [PubMed]
[2] Harada, T., Kudo, K., Fujima, N., et al. (2022) Quantitative Susceptibility Mapping: Basic Methods and Clinical Applications. Radiographics, 42, 1161-1176. [Google Scholar] [CrossRef] [PubMed]
[3] Fushimi, Y., Nakajima, S., Sakata, A., et al. (2023) Value of Quantitative Susceptibility Mapping in Clinical Neuroradiology. Journal of Magnetic Resonance Imaging. [Google Scholar] [CrossRef] [PubMed]
[4] Wei, H., Guan, X., Cao, P. and Zhang, Y.Y. (2023) Editorial: Quantitative Susceptibility Mapping: Technical Advances and Clinical Applications. Frontiers in Neuroscience, 17, Article 1228061. [Google Scholar] [CrossRef] [PubMed]
[5] Vinayagamani, S., Sheelakumari, R., Sabarish, S., et al. (2021) Quantitative Susceptibility Mapping: Technical Considerations and Clinical Applications in Neuroimaging. Journal of Magnetic Resonance Imaging, 53, 23-37. [Google Scholar] [CrossRef] [PubMed]
[6] Kames, C., Doucette, J. and Rauscher, A. (2023) Multi-Echo Dipole Inver-sion for Magnetic Susceptibility Mapping. Magnetic Resonance in Medicine, 89, 2391-2401. [Google Scholar] [CrossRef] [PubMed]
[7] Minibajeva, O., Zeltiņa, E., Karelis, G., et al. (2023) Clinical Symptoms Influencing Parkinson’s Patients’ Quality of Life in Latvia: A Single-Center Cohort Study. Medicina, 59, Article 935. [Google Scholar] [CrossRef] [PubMed]
[8] Li, K.R., Avecillas-Chasin, J., Nguyen, T.D., et al. (2022) Quanti-tative Evaluation of Brain Iron Accumulation in Different Stages of Parkinson’s Disease. Journal of Neuroimaging, 32, 363-371. [Google Scholar] [CrossRef] [PubMed]
[9] Mitchell, T., Lehéricy, S., Chiu, S.Y., et al. (2021) Emerging Neuroimaging Biomarkers across Disease Stage in Parkinson Disease: A Review. JAMA Neurology, 78, 1262-1272. [Google Scholar] [CrossRef] [PubMed]
[10] Zhang, X., Li, L., Qi, L., et al. (2023) Distribution Pattern of Iron Deposition in the Basal Ganglia of Different Motor Subtypes of Parkinson’s Disease. Neuroscience Letters, 807, Article ID: 137249. [Google Scholar] [CrossRef] [PubMed]
[11] Chen, K., Zhang, L., Mao, H., et al. (2023) The Impact of Iron Deposition on the Fear Circuit of the Brain in Patients with Parkinson’s Disease and Anxiety. Frontiers in Aging Neuro-science, 15, Article 1116516. [Google Scholar] [CrossRef] [PubMed]
[12] Marxreiter, F., Lambrecht, V., Mennecke, A., et al. (2023) Par-kinson’s Disease or Multiple System Atrophy: Potential Separation by Quantitative Susceptibility Mapping. Therapeutic Advances in Neurological Disorders, 16. [Google Scholar] [CrossRef] [PubMed]
[13] Zhang, L., Fang, J. Tang, Z. and Luo, Y.Y. (2022) A Bioinfor-matics Perspective on the Dysregulation of Ferroptosis and Ferroptosis-Related Immune Cell Infiltration in Alzheimer’s Disease. International Journal of Medical Sciences, 19, 1888-1902. [Google Scholar] [CrossRef] [PubMed]
[14] Cogswell, P.M., Wiste, H.J., Senjem, M.L., et al. (2021) Associations of Quantitative Susceptibility Mapping with Alzheimer’s Disease Clinical and Imaging Markers. Neuroimage, 224, Article ID: 117433. [Google Scholar] [CrossRef] [PubMed]
[15] Kuchcinski, G., Patin, L., Lopes, R., et al. (2023) Quantita-tive Susceptibility Mapping Demonstrates Different Patterns of Iron Overload in Subtypes of Early-Onset Alzheimer’s Disease. European Radiology, 33, 184-195. [Google Scholar] [CrossRef] [PubMed]
[16] van de Zande, N.A., Bulk, M., Najac, C., van der Weerd, L., et al. (2023) Study protOcol of IMAGINE-HD: Imaging Iron Accumulation and Neuroinflammation with 7T-MRI + CSF in Huntington’s Disease. NeuroImage: Clinical, 39, Article ID: 103450. [Google Scholar] [CrossRef] [PubMed]
[17] Chen, L., Hua, J., Ross, C.A., et al. (2019) Altered Brain Iron Content and Deposition Rate in Huntington’s Disease as Indicated by Quantitative Susceptibility MRI. Journal of Neu-roscience Research, 97, 467-479. [Google Scholar] [CrossRef] [PubMed]
[18] Jing, X.Z., Yuan, X.Z., Li, G.Y., et al. (2022) Increased Magnetic Suscepti-bility in the Deep Gray Matter Nuclei of Wilson’s Disease: Have We Been Ignoring Atrophy? Frontiers in Neuroscience, 16, Article 794375. [Google Scholar] [CrossRef] [PubMed]
[19] Coffman, C.H., White, R., Subramanian, K., et al. (2022) Quantita-tive Susceptibility Mapping of Both Ring and Non-Ring White Matter Lesions in Relapsing Remitting Multiple Sclerosis. Magnetic Resonance Imaging, 91, 45-51. [Google Scholar] [CrossRef] [PubMed]
[20] Jang, J., Nam, Y., Choi, Y., et al. (2020) Paramagnetic Rims in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder: A Quantitative Susceptibility Mapping Study with 3-T MRI. Journal of Clinical Neurology, 16, 562-572. [Google Scholar] [CrossRef] [PubMed]
[21] Dean, K.E., Shen, B., Askin, G., Schweitzer, A.D., et al. (2021) A Specific Biomarker for Amyotrophic Lateral Sclerosis: Quantitative Susceptibility Mapping. Clinical Imaging, 75, 125-130. [Google Scholar] [CrossRef] [PubMed]
[22] Bhattarai, A., Chen, Z., Ward, P.G.D., et al. (2020) Serial As-sessment of Iron in the Motor Cortex in Limb-Onset Amyotrophic Lateral Sclerosis Using Quantitative Susceptibility Mapping. Quantitative Imaging in Medicine and Surgery, 10, 1465-1476. [Google Scholar] [CrossRef] [PubMed]
[23] Li, Q., Zhu, W., Wen, X., et al. (2022) Beyond the Motor Cortex: Tha-lamic Iron Deposition Accounts for Disease Severity in Amyotrophic Lateral Sclerosis. Frontiers in Neurology, 13, Arti-cle 791300. [Google Scholar] [CrossRef] [PubMed]
[24] Haller, S., Haacke, E.M., Thurnher, M.M. and Barkhof, F. (2021) Susceptibility-Weighted Imaging: Technical Essentials and Clinical Neurologic Applications. Radiology, 299, 3-26. [Google Scholar] [CrossRef] [PubMed]
[25] Lee, K., Ellison, B., Selim, M., et al. (2023) Quantitative Suscepti-bility Mapping Improves Cerebral Microbleed Detection Relative to Susceptibility-Weighted Images. Journal of Neu-roimaging, 33, 138-146. [Google Scholar] [CrossRef] [PubMed]
[26] Reith, T.P., Prah, M.A., Choi, E.J., et al. (2022) Basal Ganglia Iron Content Increases with Glioma Severity Using Quantitative Susceptibility Mapping: A Potential Biomarker of Tumor Severity. Tomography, 8, 789-797. [Google Scholar] [CrossRef] [PubMed]
[27] Zeng, S., Ma, H., Xie, D., et al. (2023) Quantitative Susceptibil-ity Mapping Evaluation of Glioma. European Radiology, 33, 6636-6647. [Google Scholar] [CrossRef] [PubMed]
[28] Taoka, T., Fukusumi, A., Miyasaka, T., et al. (2017) Structure of the Medullary Veins of the Cerebral Hemisphere and Related Disorders. RadioGraphics, 37, 281-297. [Google Scholar] [CrossRef] [PubMed]
[29] Rudilosso, S., Chui, E., Stringer, M.S., et al. (2022) Prevalence and Significance of the Vessel-Cluster Sign on Susceptibility-Weighted Imaging in Patients with Severe Small Vessel Disease. Neurology, 99, e440-e452. [Google Scholar] [CrossRef
[30] Hoi, Y., Jang, J., Nam, Y., Shin, N.Y., et al. (2019) Rela-tionship between Abnormal Hyperintensity on T2-Weighted Images around Developmental Venous Anomalies and Magnetic Susceptibility of Their Collecting Veins: In-Vivo Quantitative Susceptibility Mapping Study. Korean Journal of Radiology, 20, 662-670. [Google Scholar] [CrossRef] [PubMed]
[31] Min, W. and Zhou, J.H. (2023) Endothelial Cell-Pericyte Interactions in the Pathogenesis of Cerebral Cavernous Malformations (CCMs). Cold Spring Harbor Perspectives in Medicine, 13, a041188. [Google Scholar] [CrossRef] [PubMed]
[32] Gillespie, C.S., Alnaham, K.E., Richardson, G.E., et al. (2023) Predictors of Future Haemorrhage from Cerebral Cavernous Malformations: A Retrospective Cohort Study. Neurosur-gical Review, 46, Article No. 52. [Google Scholar] [CrossRef] [PubMed]
[33] Incerti, I., Fusco, M., Contarino, V.E., et al. (2023) Magnetic Susceptibility as a 1-Year Predictor of Outcome in Familial Cerebral Cavernous Malformations: A Pilot Study. European Radiology, 33, 4158-4166. [Google Scholar] [CrossRef] [PubMed]
[34] Zillich, L., Poisel, E., Frank, J., et al. (2022) Multi-Omics Sig-natures of Alcohol Use Disorder in the Dorsal and Ventral Striatum. Translational Psychiatry, 12, Article No. 190. [Google Scholar] [CrossRef] [PubMed]
[35] Tan, H., Hubertus, S., Thomas, S., et al. (2023) Association between Iron Accumulation in the Dorsal Striatum and Compulsive Drinking in Alcohol Use Disorder. Psychopharma-cology, 240, 249-257. [Google Scholar] [CrossRef] [PubMed]